1. Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57:3169–3176
2. Dagogo-Jack SE, Craft S, Cryer PE (1993) Hypoglycemia- associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 91:819–828
3. Cryer PE (2002) Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45:937–948
4. Davis MR, Shamoon H (1991) Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 73:995–1001
5. Davis SN, Mann S, Galassetti P et al (2000) Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 49:1897–1903
6. Heller SR, Cryer PE (1991) Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223–226
7. Geddes J, Wright RJ, Zammitt NN, Deary IJ, Frier BM (2007) An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diab Care 30:1868–1870
8. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B (2001) Activity of angiotensin- converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet 357:1248–1253
9. Pedersen-Bjergaard U, Dhamrait SS, Sethi AA et al (2008) Genetic variation and activity of the renin–angiotensin system and severe hypoglycemia in type 1 diabetes. Am J Med 121:246–248
10. Schouwenberg BJ, Veldman BA, Spiering W et al (2008) The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus. Pharma- cogenet Genomics 18:369–372
11. Leineweber K, Brodde OE (2004) Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci 74:2803–2814
12. Green SA, Turki J, Innis M, Liggett SB (1994) Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414–9419
13. Liggett SB (2000) beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med 161:S197–S201
14. Korytkowski MT, Mokan M, Veneman TF, Mitrakou A, Cryer PE, Gerich JE (1998) Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness. Diab Care 21:1939–1943
15. Fritsche A, Stumvoll M, Grub M et al (1998) Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diab Care 21:1505–1510
16. Berlin I, Grimaldi A, Payan C et al (1987) Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin- dependent diabetic patients. Diab Care 10:742–747
17. Berlin I, Grimaldi A, Bosquet F, Puech AJ (1986) Decreased beta- adrenergic sensitivity in insulin-dependent diabetic subjects. J Clin Endocrinol Metab 63:262–265
18. Trovik TS, Jaeger R, Jorde R, Sager G (1994) Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness. Br J Clin Pharmacol 38:427–432
19. Schwab KO, Menche U, Schmeisl G, Lohse MJ (2004) Hypoglycemia-dependent beta2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with type-1 diabetes? Horm Res 62:137–141
20. Trovik TS, Vaartun A, Jorde R, Sager G (1995) Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia. Eur J Clin Pharmacol 48:327–332
21. Trovik TS, Jaeger R, Jorde R, Sager G (1995) Reduced beta- adrenergic sensitivity in healthy participants induced by hypoglycemia. Fundam Clin Pharmacol 9:181–186
22. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, MacDonald IA (1992) Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 35:287–290
23. Deary IJ, Hepburn DA, MacLeod KM, Frier BM (1993) Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 36:771–777
24. de Galan BE, De Mol P, Wennekes L, Schouwenberg BJ, Smits P (2006) Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness. J Clin Endocrinol Metab 91:2878–2881
25. Meijer P, Wouters CW, van den Broek PH et al (2008) Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation. Br J Pharmacol 153:1169–1176
26. Lenders J, Janssen GJ, Smits P, Thien T (1991) Role of the wrist cuff in forearm plethysmography. Clin Sci (Lond) 80:413–417
27. Cleaveland CR, Rangno RE, Shand DG (1972) A standardized isoproteranol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med 130:47–52
28. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
29. Ronaghi M (2003) Pyrosequencing for SNP genotyping. Methods Mol Biol 212:189–195
30. Willemsen JJ, Ross HA, Jacobs MC et al (1995) Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem 41:1455–1460
31. de Galan BE, Tack CJ, Lenders JW et al (2002) Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 51:790–796
32. Berlin I, Grimaldi A, Landault C et al (1988) Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin- dependent diabetic patients. J Clin Endocrinol Metab 66:273–278